Patients Struggling with Weight Loss Yurpeak is also approved for chronic weight management in adults with: BMI 30 kg/m (Obesity) BMI 27 kg/m with conditions such as diabetes, hypertension, fatty liver, or sleep apnea When combined with proper nutrition and exercise, patients often achieve substantial and sustained weight loss
It works to improve insulin sensitivity and help with excess weight
The Return of Food Noise Many individuals on GLP-1 medications describe the disappearance of food noisethose constant, intrusive thoughts about eating and cravings
Electrolyte Imbalance: Persistent diarrhea can cause electrolyte imbalances, disrupting normal blood and cardiovascular functions, potentially increasing clot risk
As GLP-1s help improve mobility and reduce pain tied to conditions like osteoarthritis, they can enable more consumers to re-engage with healthier lifestyles, from exercise to more intentional nutrition
Biochemical Pharmacology